Prospective evaluation for inhalation devices in greek patients with COPD and asthma: The PAIR study
ConclusionFSI-10 questionnaire had good test-retest reliability and thus can be used in the follow-up of patients with COPD, asthma and ACO. All DPIs were highly acceptable among all study groups. Elpenhaler® achieved significantly higher ratings than Diskus™ and Turbuhaler® in FSI-10 score and presented higher preference among patients with obstructive lung diseases.
Source: Pulmonary Pharmacology and Therapeutics - Category: Respiratory Medicine Source Type: research
More News: Asthma | Chronic Obstructive Pulmonary | Drugs & Pharmacology | Greece Health | Respiratory Medicine | Study